Scientific Presentations

Press releases
Corporate presentation
Scientific Presentations
Scientific Publications
Events and webcasts
Stock information
SEC filings
Financial Statements
Regulated information
Voting Rights & Share Capital
ATM Program
General meetings
Governance
The board and committee members
Corporate governance documents
FAQ
IR Inquiry
All 2024 2023 2022 2021
05 Jun 2023
03:27 E.S.T.

Non-viral DNA delivery associated to TALEN® gene editing leads to highly efficient correction of sickle cell mutation in long-term repopulating hematopoietic stem cells  - ISCT 2023 - Poster Presentation

Download the PDF file
17 May 2023
18:55 E.S.T.

Expanding the Scope of Multiplex Engineering for Superior Generation of Efficient CAR T-cells - ASGCT 2023 - Poster Presentation

Download the PDF file
17 May 2023
14:30 E.S.T.

AMELI 01: A Phase I Trial of UCART123v1.2, an Anti CD123 Allogeneic CAR T Cell Product, in Adult Patients with Relapsed or Refractory (R/R) CD123+ Acute Myeloid Leukemia - ASGCT 2023 - Oral Presentation

Download the PDF file
16 Apr 2023
08:00 E.S.T.

Deciphering the benefits of variable delivery routes and molecular armoring to enhance efficacy of MUC1-CAR T-cells in targeting triple-negative breast cancer - AACR 2023 - Poster presentation

Download the PDF file